Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2023-05-23T17:30:23+0100
COVID-19
ASX 200: three stocks to watch as of 6 February
Tony Sycamore analyses three ASX-listed Healthcare stocks and explores if they build on recent gains.
2023-02-06T00:33:30+0000
NYSE: GSK share price and Q4 earnings results preview
What to expect and how to trade GSK’s upcoming results
2023-01-30T13:07:16+0000
TUI capital raise sends shares down
TUI, the world’s largest holiday travel company, says it will raise between €1.6 and €1.7 billion to pay down the Covid assistance money received from the German government.
2022-12-14T10:39:10+0000
Can the Hang Seng extend its re-opening recovery?
As China’s rapid relaxation of its Covid Zero strategy continues, the recent market changes have caught analysts by surprise, however, the key question is: can the recovery be extended and what can we expect from the Hang Seng?
2022-12-14T05:36:52+0000
Outlook 2023: Iron ore and copper prices could benefit from China recovery
China stimulus and relaxation of covid restrictions are likely to benefit copper and iron ore prices and in turn diversified miners
2022-12-13T07:43:31+0000
The Hang Seng reacts to new Covid measures
As China confirmed to ease some of its strict Covid measures despite not changing its Covid-Zero policy, what can we expect from the embattled Hang Seng?
2022-11-16T03:53:01+0000
Moderna’s share price on watch ahead of Q3 earnings
Moderna’s share price is down close to 40% year-to-date, as Covid-19 risks took a backseat. What can we look forward to in the upcoming Q3 results?
2022-11-02T06:42:27+0000
Watching USD/CNH as Chinese slowdown accelerates
There’s more evidence that China’s zero-Covid policy is impacting on local gross domestic product (GDP).
2022-10-31T09:58:02+0000
